Cellectar Biosciences, Inc. Operating Leases, Future Minimum Payments, Due in Four Years
Cellectar Biosciences, Inc. (CLRB) had Operating Leases, Future Minimum Payments, Due in Four Years of $161.12 thousand as of 2019-12-31, per its 10-K filed 2020-03-09.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2020-03-09
- 2019-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $161.12K.
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $161.09K; Operating Leases, Future Minimum Payments, Due in Four Years as first filed $158.24K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years | Operating Leases, Future Minimum Payments, Due in Four Years as first filed |
|---|---|---|
| 2019-12-31 | $161.12K 10-K · filed 2020-03-09 | |
| 2018-12-31 | $161.09K 10-Q · filed 2019-11-12 | $158.24K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |